Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apremilast Alters Behavioral Responses to Ethanol in Mice: I. Reduced Consumption and Preference
Yuri A. Blednov, Adriana J. Da Costa, Tamara Tarbox, et al.
Alcoholism Clinical and Experimental Research (2018) Vol. 42, Iss. 5, pp. 926-938
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Neuroimmune signaling in alcohol use disorder
Emma K. Erickson, Emily K. Grantham, Anna S. Warden, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 177, pp. 34-60
Open Access | Times Cited: 185
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 152
Immune treatments for alcohol use disorder: A translational framework
Lindsay R. Meredith, Elizabeth M. Burnette, Erica N. Grodin, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 349-364
Open Access | Times Cited: 41
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 219-232
Closed Access | Times Cited: 5
Alcohol and Alzheimer's—Is there a link?
HENRY M ZEIDAN, IMAN H ZEIDAN
Elsevier eBooks (2025), pp. 129-174
Closed Access
Cell-type brain-region specific changes in prefrontal cortex of a mouse model of alcohol dependence
Nihal A. Salem, L.A. Manzano, Michael W. Keist, et al.
Neurobiology of Disease (2023) Vol. 190, pp. 106361-106361
Open Access | Times Cited: 9
Apremilast-induced increases in acute ethanol intoxication and decreases in ethanol drinking in mice involve PKA phosphorylation of GABAA β3 subunits
Yuri A. Blednov, Adriana Da Costa, Sonia Mason, et al.
Neuropharmacology (2022) Vol. 220, pp. 109255-109255
Open Access | Times Cited: 14
Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats
Adel A. Gomaa, Hanan S.M. Farghaly, Asmaa M. Ahmed, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109927-109927
Closed Access | Times Cited: 8
Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic drugs in mice
Yuri A. Blednov, Adriana Da Costa, Sonia Mason, et al.
Neuropharmacology (2023) Vol. 231, pp. 109508-109508
Open Access | Times Cited: 8
Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review
Saeideh Karimi‐Haghighi, Sara Chavoshinezhad, Roghayeh Mozafari, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 2, pp. 649-682
Closed Access | Times Cited: 13
Apremilast Alters Behavioral Responses to Ethanol in Mice: II. Increased Sedation, Intoxication, and Reduced Acute Functional Tolerance
Yuri A. Blednov, Adriana J. Da Costa, R. Adron Harris, et al.
Alcoholism Clinical and Experimental Research (2018) Vol. 42, Iss. 5, pp. 939-951
Open Access | Times Cited: 21
Persistence of apremilast in moderate‐to‐severe psoriasis: a real‐world analysis of 14 147 apremilast‐ and methotrexate‐naive patients in the French National Health Insurance database
É. Sbidian, Cécile Billionnet, Alain Weill, et al.
British Journal of Dermatology (2019) Vol. 182, Iss. 3, pp. 690-697
Closed Access | Times Cited: 20
The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
Murlidhar Rajagopalan, Sunil Dogra, Abir Saraswat, et al.
Psoriasis Targets and Therapy (2021) Vol. Volume 11, pp. 109-122
Open Access | Times Cited: 17
Transcriptome Analysis of Alcohol Drinking in Non-Dependent and Dependent Mice Following Repeated Cycles of Forced Swim Stress Exposure
Sean P. Farris, Gayatri R. Tiwari, Olga Ponomareva, et al.
Brain Sciences (2020) Vol. 10, Iss. 5, pp. 275-275
Open Access | Times Cited: 16
Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders
Leigh C. Walker, Andrew J. Lawrence
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 8, pp. 677-690
Closed Access | Times Cited: 18
Deletion of Tlr3 reduces acute tolerance to alcohol and alcohol consumption in the intermittent access procedure in male mice
Yuri A. Blednov, Adriana Da Costa, Jody Mayfield, et al.
Addiction Biology (2020) Vol. 26, Iss. 2
Open Access | Times Cited: 15
KVA-D-88, a Novel Preferable Phosphodiesterase 4B Inhibitor, Decreases Cocaine-Mediated Reward Properties in Vivo
Maria Burkovetskaya, Qiaoling Liu, Anish K. Vadukoot, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 15, pp. 2231-2242
Open Access | Times Cited: 13
Apremilast regulates acute effects of ethanol and other GABAergic drugs via protein kinase A-dependent signaling
Yuri A. Blednov, Cecilia M. Borghese, Michael P. Dugan, et al.
Neuropharmacology (2020) Vol. 178, pp. 108220-108220
Open Access | Times Cited: 8
Targeting the Maladaptive Effects of Binge Drinking on Circadian Gene Expression
Kolter B. Grigsby, Courtney Ledford, Tanvi Batish, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11084-11084
Open Access | Times Cited: 4
Neuroimmune pathways as targets to reduce alcohol consumption
Emily K. Grantham, Riccardo Barchiesi, Nihal A. Salem, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 222, pp. 173491-173491
Open Access | Times Cited: 4
The FDA-approved drug apremilast suppresses alcohol intake: clinical and pre-clinical validation
Kolter B. Grigsby, Regina A. Mangieri, Amanda J. Roberts, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Inhibition of the Sodium–Calcium Exchanger Reverse Mode Activity Reduces Alcohol Consumption in Rats
Gleice Kelli Silva-Cardoso, Prosper N’Gouemo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4132-4132
Open Access
The PDE4 inhibitor apremilast modulates ethanol responses in Gabrb1-S409A knock-in mice via PKA-dependent and independent mechanisms
Yuri A. Blednov, William Shawlot, Gregg E. Homanics, et al.
Neuropharmacology (2024) Vol. 257, pp. 110035-110035
Closed Access
Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury
Dalton W. Staller, Robert G. Bennett, Ram I. Mahato
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 7, pp. 545-573
Closed Access
Alcohol drinking is attenuated by PDE4 inhibition but partial microglia depletion is not sufficient to block stress-induced escalation of alcohol intake in female mice
Vernon Garcia‐Rivas, Alexa R. Soares, Merrilee Thomas, et al.
Alcohol (2024) Vol. 122, pp. 31-42
Closed Access
Page 1 - Next Page

Scroll to top